Reprise Biomedical develops and commercializes novel biologic medical devices that address unmet needs in advanced wound care. Licensed from the University of Minnesota, our proprietary perfusion decellularization technology enables the Miro3D wound matrix, a completely unique 2 cm thick scaffold designed for deep, tunneling, and complex wounds. Unlike flat-sheet competitors, our products provide true three-dimensional solutions that conform to irregular wound geometries and promote tissue regeneration. Product extensions include Miro3D Fibers (particles), MiroTract (matrix on a wire for tunnel delivery), and MiroDry (1 cm matrix), expanding our portfolio to meet a broad range of clinical applications.
Aroa Biosurgery, Inc.
Aroa Biosurgery was founded in 2008 and is headquartered in Auckland, New Zealand. AROA is a soft-tissue regeneration company with a range of products for complex wounds and soft tissue reconstruction. The portfolio spans all sites of care, and is based on AROA ECM technology – derived from sheep forestomach. The AROA Portfolio: Endoform™ Natural, Endoform™ Antimicrobial, Myrad Matrix™, Myriad Morcells™, Myriad Morcells Fine™ and Symphony™